- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 12, 2026 | 14.64M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 13.69M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 12.08M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 4.91M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 4.83M sh |
| Capex | Q3 2026 · Dec 31, 2025 | $925K |
| Capex | Q3 2026 · Dec 31, 2024 | $4.32M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$37.44M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | −$20.35M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $13.18M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $16.46M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $20.38M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$184.23M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$160.5M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$164.37M |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | −$196.62M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2024 | −$151.1M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | −$121.5M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $203.18M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $257.61M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $333.5M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $319.77M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $103.62M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $102.81M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $149.27M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $155.4M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$2.03 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$7.58 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$15.35 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$22.22 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$2.03 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$7.58 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$15.35 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$22.22 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $10.05M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $34.62M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $14.14M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $49.19M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $5.57M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $17.93M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $7.68M |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $24.26M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$27.84M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$91.51M |
| Net Income restated | Q3 2026 · Dec 31, 2024 | −$75.3M |
| Net Income restated | Q3 2026 · Dec 31, 2024 | −$107.35M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$1.19M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$21.94M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$7.73M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$30.09M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $28.93M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $75.2M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $27.89M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $85.59M |
| Revenue | Q3 2026 · Dec 31, 2025 | $74.59M |
| Revenue | Q3 2026 · Dec 31, 2025 | $201.59M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $68.68M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $212.8M |